Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Accumulated Depreciation & Amortization: 2013-2017

  • Armata Pharmaceuticals' Accumulated Depreciation & Amortization rose 25.54% to $1.2 million in Q4 2017 from the same period last year, while for Dec 2017 it was $3.2 million, marking a year-over-year increase of 34.63%. This contributed to the annual value of $1.2 million for FY2017, which is 25.54% up from last year.
  • Per Armata Pharmaceuticals' latest filing, its Accumulated Depreciation & Amortization stood at $1.2 million for Q4 2017, which was up 25.54% from $932,000 recorded in Q4 2016.
  • In the past 5 years, Armata Pharmaceuticals' Accumulated Depreciation & Amortization registered a high of $1.2 million during Q4 2017, and its lowest value of $351,000 during Q4 2013.
  • For the 3-year period, Armata Pharmaceuticals' Accumulated Depreciation & Amortization averaged around $902,000, with its median value being $932,000 (2016).
  • Data for Armata Pharmaceuticals' Accumulated Depreciation & Amortization shows a peak YoY soared of 54.30% (in 2016) over the last 5 years.
  • Armata Pharmaceuticals' Accumulated Depreciation & Amortization (Quarterly) stood at $351,000 in 2013, then spiked by 36.18% to $478,000 in 2014, then increased by 26.36% to $604,000 in 2015, then spiked by 54.30% to $932,000 in 2016, then increased by 25.54% to $1.2 million in 2017.
  • Its last three reported values are $1.2 million in Q4 2017, $932,000 for Q4 2016, and $604,000 during Q4 2015.